Immunai, to map immune system for better diagnosis, disease treatment
Healthcare IT News - 14-May-2020This application of machine learning will soon speed up drug development
Join the club for FREE to access the whole archive and other member benefits.
CEO and Co-founder, Immunai
Noam Solomon
I am the CEO and co-founder of a stealth-mode start-up company.
In the year 2018-2019, I was a post-doctoral researcher in the Mathematics department at MIT, hosted by Professor Larry Guth.
In the year 2017-2018, I was a post-doctoral researcher in the CMSA, the center of mathematical sciences and applications at Harvard University.
In my research I develop and apply tools from Algebra and Algebraic Geometry in the study of classical problems in Combinatorics, especially in Combinatorial Geometry.
I completed my Ph.D in the School of Computer Science in Tel-Aviv University, under the supervision of Professor Micha Sharir.
Here's my dissertation entitled Algebraic Techniques in Combinatorial and Computational Geometry
Before that, I completed a Ph.D in Pure Mathematics in Ben-Gurion University under the supervision of Professor Amnon Besser.
Here's my dissertation entitled P-adic Elliptic Polylogarithms and Arithmetic Applications
CONTACT INFORMATION
Email: noam.solom@gmail.com
Visit website: https://sites.google.com/site/noamsolomonswebpage/home/
See also: Immunai - Biotech company, New York
Details last updated 19-May-2020
This application of machine learning will soon speed up drug development